UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027596
Receipt number R000031395
Scientific Title A validation study to evaluate a novel cancer screening using C. elegans
Date of disclosure of the study information 2017/06/01
Last modified on 2023/01/05 19:52:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A validation study to evaluate a novel cancer screening using C. elegans

Acronym

A validation study to evaluate a novel cancer screening using C. elegans

Scientific Title

A validation study to evaluate a novel cancer screening using C. elegans

Scientific Title:Acronym

A validation study to evaluate a novel cancer screening using C. elegans

Region

Japan


Condition

Condition

All malignancies

Classification by specialty

Gastroenterology Hepato-biliary-pancreatic medicine Pneumology
Hematology and clinical oncology Surgery in general Gastrointestinal surgery
Hepato-biliary-pancreatic surgery Chest surgery Breast surgery
Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficiency of N-NOSE which is the new cancer screening using C.elegans.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To calculate the sensitivity and specificity of N-NOSE for various cancers and examine speriority with the existing tumor markers.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. all patients who visit our hospital.
2. patients who consent to this study.
3. In the cancer patients, Informed consent is carried out and the fact of cancer is announced.

Key exclusion criteria

1. the one who can not obtain urine sample such as dyalysis patients

Target sample size

900


Research contact person

Name of lead principal investigator

1st name Shomei
Middle name
Last name Ryozawa

Organization

Saitama Medical University International Medical Center

Division name

Department of Gastroenterology

Zip code

350-1298

Address

1397-4 Yamane, Hidaka, Saitama 350-1298, Japan

TEL

042-984-4111

Email

ryozawa@saitama-med.ac.jp


Public contact

Name of contact person

1st name Masanori
Middle name
Last name Kobayashi

Organization

Saitama Medical University International Medical Center

Division name

Department of Gastroenterology

Zip code

350-1298

Address

1397-4 Yamane, Hidaka, Saitama 350-1298, Japan

TEL

042-984-4111

Homepage URL


Email

mkobayashi.gast@tmd.ac.jp


Sponsor or person

Institute

Saitama Medical University International Medical Center

Institute

Department

Personal name



Funding Source

Organization

self-sustaining

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Saitama Medical University International Medical Center, Center for the Promotion of Appropriate Clinical Research

Address

1397-4 Yamane, Hidaka, Saitama 350-1298, Japan

Tel

042-984-4523

Email

chikens@saitama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

441

Results

There were 95 noncancer cases and 104 pancreatic cancer cases. The sensitivity and specificity of N-NOSE for pancreatic cancer were
84.6% (88/104) and 60%(57/95), respectively. N-NOSE was able to detect stages 0 to I pancreatic cancer and had a higher correlation with early-stage pancreatic cancer than advanced stage.

Results date posted

2021 Year 06 Month 04 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2021 Year 05 Month 01 Day

Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2017 Year 05 Month 24 Day

Date of IRB

2017 Year 05 Month 24 Day

Anticipated trial start date

2017 Year 06 Month 13 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry

2023 Year 03 Month 31 Day

Date trial data considered complete

2023 Year 03 Month 31 Day

Date analysis concluded

2023 Year 03 Month 31 Day


Other

Other related information

This study is the analytic observational study. The patients who visit our hospital from 1st June 2017 to 31st march 2019 are include if they meet the selection criteria. The urine samples are obtained for N-NOSE from all of them. Moreover, age, sex, height, body weight, diagnosis, disease stage, the results of image examination, pathological diagnosis, treatment regimen, past medical histories, family histories, complications and the result of blood test are collected.


Management information

Registered date

2017 Year 06 Month 01 Day

Last modified on

2023 Year 01 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031395


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name